Search Results

There are 4995 results for: content related to: Stability of 1% voriconazole solution in a constant-rate infusion pump for topical ocular delivery to horses

  1. Monitoring trough voriconazole plasma concentrations in haematological patients: real life multicentre experience

    Mycoses

    Volume 55, Issue 6, November 2012, Pages: 483–492, Zdenek Racil, Jana Winterova, Michal Kouba, Pavel Zak, Ludmila Malaskova, Lucie Buresova, Martina Toskova, Martina Lengerova, Iva Kocmanova, Barbora Weinbergerova, Shira Timilsina, Monika Rolencova, Petr Cetkovsky and Jiri Mayer

    Version of Record online : 19 MAR 2012, DOI: 10.1111/j.1439-0507.2012.02186.x

  2. Anti-infectious activity of intravitreal injectable voriconazole microspheres on experimental rabbit fungal endophthalmitis caused by aspergillus fumigatus

    Journal of Pharmaceutical Sciences

    Volume 100, Issue 5, May 2011, Pages: 1745–1759, Wu Xiang-Gen, Yang Li-Na, Xin Meng and Jiang Hao-Ran

    Version of Record online : 24 NOV 2010, DOI: 10.1002/jps.22402

  3. Safety and Pharmacokinetics of Coadministered Voriconazole and Anidulafungin

    The Journal of Clinical Pharmacology

    Volume 45, Issue 12, December 2005, Pages: 1373–1382, Dr James A. Dowell, Dr Jennifer Schranz, Dr Alice Baruch and Dr Grover Foster

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270005281234

  4. Corneal stromal abscessation in two horses treated with intracorneal and subconjunctival injection of 1% voriconazole solution

    Veterinary Ophthalmology

    Volume 16, Issue 6, November 2013, Pages: 451–458, Hiroki Tsujita and Caryn E. Plummer

    Version of Record online : 10 DEC 2012, DOI: 10.1111/vop.12014

  5. Pharmacoeconomic analysis of voriconazole vs. caspofungin in the empirical antifungal therapy of febrile neutropenia in Australia

    Mycoses

    Volume 55, Issue 3, May 2012, Pages: 244–256, Daoud Al-Badriyeh, Danny Liew, Kay Stewart and David C. M. Kong

    Version of Record online : 26 JUL 2011, DOI: 10.1111/j.1439-0507.2011.02074.x

  6. Voriconazole exposure and the risk of cutaneous squamous cell carcinoma in allogeneic hematopoietic stem cell transplant patients

    Transplant Infectious Disease

    Volume 17, Issue 2, April 2015, Pages: 250–258, D.J. Wojenski, G.T. Bartoo, J.A. Merten, R.A. Dierkhising, M.R. Barajas, R.A. el-Azhary, J.W. Wilson, M.F. Plevak, W.J. Hogan, M.R. Litzow, M.M. Patnaik, R.C. Wolf and S.K. Hashmi

    Version of Record online : 26 MAR 2015, DOI: 10.1111/tid.12367

  7. Pharmacokinetic Interaction Between Voriconazole and Efavirenz at Steady State in Healthy Male Subjects

    The Journal of Clinical Pharmacology

    Volume 48, Issue 1, January 2008, Pages: 73–84, Mr Ping Liu, Dr Grover Foster, Mr Rober R. LaBadie, Dr Mari J. Gutierrez and Dr Amarnath Sharma

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270007309703

  8. Voriconazole N-oxide and its ultraviolet B photoproduct sensitize keratinocytes to ultraviolet A

    British Journal of Dermatology

    Volume 173, Issue 3, September 2015, Pages: 751–759, K. Ona and D.H. Oh

    Version of Record online : 20 JUL 2015, DOI: 10.1111/bjd.13862

  9. You have free access to this content
    Voriconazole concentrations and outcome of invasive fungal infections

    Clinical Microbiology and Infection

    Volume 16, Issue 7, July 2010, Pages: 927–933, S. Miyakis, S. J. van Hal, J. Ray and D. Marriott

    Version of Record online : 20 OCT 2009, DOI: 10.1111/j.1469-0691.2009.02990.x

  10. Importance of voriconazole therapeutic drug monitoring in pediatric cancer patients with invasive aspergillosis

    Pediatric Blood & Cancer

    Volume 60, Issue 1, January 2013, Pages: 82–87, Soo-Han Choi, Soo-Youn Lee, Ji-Young Hwang, Soo Hyun Lee, Keon Hee Yoo, Ki Woong Sung, Hong Hoe Koo and Yae-Jean Kim

    Version of Record online : 8 AUG 2012, DOI: 10.1002/pbc.24262

  11. You have free access to this content
    Pharmacokinetic interactions of efavirenz and voriconazole in healthy volunteers

    British Journal of Clinical Pharmacology

    Volume 65, Issue 4, April 2008, Pages: 523–530, Bharat Damle, Robert LaBadie, Penelope Crownover and Paul Glue

    Version of Record online : 20 FEB 2008, DOI: 10.1111/j.1365-2125.2007.03085.x

  12. You have free access to this content
    Pharmacokinetics, metabolism and bioavailability of the triazole antifungal agent voriconazole in relation to CYP2C19 genotype

    British Journal of Clinical Pharmacology

    Volume 68, Issue 6, December 2009, Pages: 906–915, Ina Scholz, Heike Oberwittler, Klaus-Dieter Riedel, Jürgen Burhenne, Johanna Weiss, Walter E. Haefeli and Gerd Mikus

    Version of Record online : 1 SEP 2009, DOI: 10.1111/j.1365-2125.2009.03534.x

  13. You have free access to this content
    Antifungal prophylaxis in haematology patients: the role of voriconazole

    Clinical Microbiology and Infection

    Volume 18, Issue s2, April 2012, Pages: 1–15, Y. Hicheri, G. Cook and C. Cordonnier

    Version of Record online : 12 MAR 2012, DOI: 10.1111/j.1469-0691.2012.03772.x

  14. CYP2C19 Polymorphisms and Therapeutic Drug Monitoring of Voriconazole: Are We Ready for Clinical Implementation of Pharmacogenomics?

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 34, Issue 7, July 2014, Pages: 703–718, Aniwaa Owusu Obeng, Eric F. Egelund, Abdullah Alsultan, Charles A. Peloquin and Julie A. Johnson

    Version of Record online : 7 FEB 2014, DOI: 10.1002/phar.1400

  15. You have free access to this content
    Pharmacokinetics and tolerability of voriconazole and a combination oral contraceptive co-administered in healthy female subjects

    British Journal of Clinical Pharmacology

    Volume 65, Issue 4, April 2008, Pages: 531–539, Emma Andrews, Bharat D. Damle, Annie Fang, Grover Foster, Penelope Crownover, Robert LaBadie and Paul Glue

    Version of Record online : 21 FEB 2008, DOI: 10.1111/j.1365-2125.2007.03084.x

  16. Investigation of the Potential Relationships Between Plasma Voriconazole Concentrations and Visual Adverse Events or Liver Function Test Abnormalities

    The Journal of Clinical Pharmacology

    Volume 46, Issue 2, February 2006, Pages: 235–243, Dr Keith Tan, Mr Nigel Brayshaw, Dr Konrad Tomaszewski, Dr Peter Troke and Dr Nolan Wood

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270005283837

  17. You have free access to this content
    Consensus guidelines for optimising antifungal drug delivery and monitoring to avoid toxicity and improve outcomes in patients with haematological malignancy, 2014

    Internal Medicine Journal

    Volume 44, Issue 12b, December 2014, Pages: 1364–1388, M. M. Chau, D. C. M. Kong, S. J. van Hal, K. Urbancic, J. A. Trubiano, M. Cassumbhoy, J. Wilkes, C. M. Cooper, J. A. Roberts, D. J. E. Marriott and L. J. Worth

    Version of Record online : 8 DEC 2014, DOI: 10.1111/imj.12600

  18. Pharmacokinetics and distribution of voriconazole in body fluids of dogs after repeated oral dosing

    Journal of Veterinary Pharmacology and Therapeutics

    Volume 38, Issue 5, October 2015, Pages: 451–456, J. D. Lemetayer, P. M. Dowling, S. M. Taylor and M. G. Papich

    Version of Record online : 18 FEB 2015, DOI: 10.1111/jvp.12208

  19. You have free access to this content
    Coadministration of voriconazole and phenytoin: pharmacokinetic interaction, safety, and toleration

    British Journal of Clinical Pharmacology

    Volume 56, Issue s1, December 2003, Pages: 37–44, Lynn Purkins, Nolan Wood, Parviz Ghahramani, Edward R. Love, Malcolm D. Eve and Anitra Fielding

    Version of Record online : 17 NOV 2003, DOI: 10.1046/j.1365-2125.2003.01997.x

  20. Pharmacokinetics and Short-Term Safety of Etravirine in Combination With Fluconazole or Voriconazole in HIV-Negative Volunteers

    The Journal of Clinical Pharmacology

    Volume 53, Issue 1, January 2013, Pages: 41–50, Thomas N. Kakuda, Rodica Van Solingen-Ristea, Fatima Aharchi, Goedele De Smedt, James Witek, Steven Nijs, Veerle Vyncke and Richard M. W. Hoetelmans

    Version of Record online : 24 JAN 2013, DOI: 10.1177/0091270011433329